Renae Slobodny
Medical · Phoenix, AZNPI 1528586641
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,656, more than ten times the $151 reported in 2021.
Across 149 payments — averaging $29.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$891
- AbbVie$497
- Regeneron Healthcare Solutions, Inc.$411
- Johnson & Johnson$328
- Dermavant Sciences, Inc.$257
- Galderma Laboratories, L.p.$223
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,449100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 24 | $891 |
| AbbVie | 20 | $497 |
| Regeneron Healthcare Solutions, Inc. | 12 | $411 |
| Johnson & Johnson | 10 | $328 |
| Dermavant Sciences, Inc. | 11 | $257 |
| Galderma Laboratories, L.p. | 6 | $223 |
| Organon | 6 | $213 |
| Incyte Corporation | 6 | $197 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $186 |
| UCB, Inc. | 8 | $181 |
| Sun Pharmaceutical Industries Inc. | 7 | $162 |
| Almirall LLC | 2 | $140 |
| Lilly USA, LLC | 6 | $126 |
| Blueprint Medicines Corporation | 4 | $107 |
| E.r. Squibb & Sons, L.L.C. | 5 | $106 |
| Novartis | 3 | $95 |
| Amgen | 4 | $83 |
| Organogenesis Inc. | 3 | $71 |
| LEO Pharma Inc. | 2 | $47 |
| Revance Therapeutics, Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $24 |
| LNHC, Inc | 1 | $22 |
| Journey Medical Corporation | 1 | $19 |
| Mimedx Group, Inc. | 1 | $17 |
| Biowound Solutions, Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,449 in reported general payments places this provider in the 80th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 38 | $1,604 |
| Ketoconazole | 82 | $1,365 |
| ValacyclovirValacyclovir Hcl | 27 | $501 |
| Doxycycline Hyclate | 28 | $422 |
| Triamcinolone Acetonide | 21 | $246 |
| Cephalexin | 58 | $123 |
| Mupirocin | 24 | $90 |
Paid to pharmacies, not to this prescriber.
Other medical in Phoenix
- Scott YoungPhoenix$69K
- Scott LightfootPhoenix$61K
- Jennifer KiserPhoenix$53K
- Lakeisha ColterPhoenix$48K
- Amy IngersollPhoenix$42K
- Ty NielsonPhoenix$18K
- Brittany SilvermanPhoenix$16K
- John RimerPhoenix$15K
- Rana AoufePhoenix$14K
- Adam SchwartzPhoenix$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.